Sign in
4

Changes in Ownership

Theriva Biologics, Inc. Filed Acc 0000890163-07-000253

Chief Executive Officer bought 227,000 shares at an average $1.96 ($445,580)

From the SEC's structured data for this filing

Trades in this filing

KANZER STEVE H · Chief Executive Officer

Table I: Non-derivative

17 lines
Date Transaction Shares Price Value Owned after D/I
2007-04-16 Purchase : show line 1 in the form +2,000 $1.82 $3,640 197,238 D
2007-04-16 Purchase : show line 2 in the form +2,000 $1.83 $3,660 199,238 D
2007-04-16 Purchase : show line 3 in the form +41,000 $1.84 $75,440 240,238 D
2007-04-16 Purchase : show line 4 in the form +2,500 $1.85 $4,625 242,738 D
2007-04-16 Purchase : show line 5 in the form +10,000 $1.86 $18,600 252,738 D
2007-04-16 Purchase : show line 6 in the form +2,500 $1.87 $4,675 255,238 D
2007-04-16 Purchase : show line 7 in the form +32,500 $1.95 $63,375 287,738 D
2007-04-16 Purchase : show line 8 in the form +10,000 $1.99 $19,900 297,738 D
Open-market purchases · 227,000 sh · avg $1.96 · $445,580

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2006-01-27 Grant or award : show line 18 in the form Warrants +3,618,735 3,618,735 I
2007-01-07 Grant or award : show line 19 in the form Warrants +22,953 22,953 D
Loading xslF345X02/s11-7312_ex.xml…